STEMCELL and Axion BioSystems Partner to Optimize Excitable Cell Culture and Analysis

Axion BioSystems and STEMCELL Technologies are excited to announce a strategic partnership that will see STEMCELL distributing Axion’s advanced Maestro Pro™ and Maestro Edge™ multielectrode array (MEA) systems across North America and Europe. The Maestro MEA systems will also remain…

Read MoreSTEMCELL and Axion BioSystems Partner to Optimize Excitable Cell Culture and Analysis

Life Spine Publishes Study on Discectomy Performance: Endoscopic vs. MIS Tubular Approach in TLIF

Life Spine, Inc., a medical device company specializing in products for spinal disorder treatments, announced that the international peer-reviewed journal Spine has published a new study comparing discectomy performance during Transforaminal Lumbar Interbody Fusion (TLIF) using an endoscopic technique versus…

Read MoreLife Spine Publishes Study on Discectomy Performance: Endoscopic vs. MIS Tubular Approach in TLIF

ImmunoPrecise Antibodies (IPA) Announces Q1 Fiscal 2025 Financial Results and Highlights

ImmunoPrecise Antibodies Ltd (IPA) (NASDAQ: IPA), a biotherapeutics research and technology company utilizing artificial intelligence, has reported its financial results for the first quarter of fiscal 2025, ending July 31, 2024. All figures are presented in Canadian dollars (CAD) unless…

Read MoreImmunoPrecise Antibodies (IPA) Announces Q1 Fiscal 2025 Financial Results and Highlights